東方生物(688298.SH):上海祥禾及其一致行動人擬減持不超9%的股份
格隆匯 2 月 5日丨東方生物(688298.SH)公佈,截至公吿披露日,公司股東上海祥禾湧安股權投資合夥企業(有限合夥)(“上海祥禾”)及其一致行動人上海湧創鏵興投資合夥企業(有限合夥)(“上海湧創”)、連雲港湧誠股權投資合夥企業(有限合夥)(“連雲港湧誠”)分別持有公司1423.845萬股、213.75萬股、106.875萬股股份,佔公司股份總數的11.87%、1.78%、0.89%。上海祥禾、上海湧創、連雲港湧誠3家企業均受自然人陳金霞控制,具有一致行動關係,合計持有公司股份1744.47萬股,佔公司股份總數的14.54%。
上述股份均為公司首次公開發行前取得的股份,於2021年2月5日解除限售後上市流通。
上海祥禾、上海湧創、連雲港湧誠因自身資金需要,擬在減持計劃披露的減持期間內,通過集中競價、大宗交易方式合計減持公司股份數量不超過1080萬股,不超過公司股份總數的9%。其中,通過集中競價方式合計減持不超過360萬股,不超過公司股份總數的3%,且在任意連續60 日內減持股份的總數不超過公司股份總數的1%;通過大宗交易方式合計減持不超過720萬股,不超過公司總股本的6%,且在任意連續60日內減持股份的總數不超過公司股份總數的2%。若在上述減持期間,公司有送紅股、轉增股本、增發新股等股份變動事項,對應的減持股份數量將進行相應的調整。減持價格按照市場價格確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.